ETF Comparison

HLTH vs IHI: Which Is the Better Pick in 2026?

A head-to-head comparison of Tema Healthcare AI ETF and iShares U.S. Medical Devices ETF covering yield, cost, risk, and income potential.

Data updated September 18, 2026

Visual comparison

Key metrics

Projected income on $10K

Projections assume the current yield and share price remain constant. Actual results will vary.

Total returns

100% reinvested · ex-date convention. Period returns use this fixed assumption, independent of chart settings.

HLTH has outpaced IHI over the shared window since Jul 2026, posting a 15.77% total return against 3.81%. Figures are total returns: price change plus every distribution reinvested.

Total return and risk statistics by fund. Each row is one fund; each column is one period or statistic.
Symbol	Since Jul 2026
HLTH	15.77%
IHI	3.81%

Total return with all distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date), split-adjusted, as of September 18, 2026. YTD and 1Y are cumulative; windows of one year or longer are annualized. “Since Jul 2026” measures every fund from July 21, 2026 — the start of shared available history — so all funds share one comparison window.

Side-by-side snapshot

Side-by-side snapshot. Each row is one metric; each column is one fund.
Metric	HLTH	IHI
Full name	Tema Healthcare AI ETF	iShares U.S. Medical Devices ETF
Issuer	Tema ETFs	iShares
Last Close	$29.30 as of September 18, 2026	$51.77 as of September 18, 2026
Distribution rate	—	0.63%
Distribution Safety Score™	—	83
Safety-Adjusted Yield	—	0.52%
Expense ratio	0.75%	0.37%
AUM	$8.67M	$3.56B
Distribution frequency	None	Quarterly
Underlying index	—	—
Objective	Seeks long-term capital appreciation through an actively managed portfolio of companies applying artificial intelligence across healthcare — including AI-driven drug discovery, diagnostics, medical imaging, medical devices, and healthcare IT platforms.	—
Asset class	Equity	Equity
Inception date	07/21/2026	05/01/2006
Beta	—	0.79
Last dividend	—	$0.081 payable today
Ex-dividend date	—	09/15/2026

— Distribution rate, Safety-Adjusted Yield, last dividend, and ex-dividend date are not yet available because HLTH launched July 2026; these fields will populate after the first distribution.

Bottom lineWe won't call this one: HLTH launched July 2026, so there is not yet a track record to compare. Compare the strategy, cost and holdings in the sections above and treat any performance figures for the newer ETF as provisional. What is already clear from the numbers above: the two do not cost the same — IHI charges 0.37% against 0.75% for HLTH, and on funds tracking the same thing that gap compounds every year you hold.

Model this comparison:

Compare in my portfolio Forecast income Save to watchlist

Income calculator

See how much monthly income a hypothetical investment would generate in each ETF at current yields.

Tema ETFs

ETFs13

Total AUM$3.80B

ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.

Tema ETFs is known for offering thematically focused and income-oriented strategies that target specific industries and trends rather than broad market exposure. The issuer's lineup spans both income-generating funds and thematic investments centered on sectors such as defense, healthcare, technology, and infrastructure, with tickers including ARMY, CANC, DSPY, HLTH, LAZR, NASA, and VOLT. Tema's approach appeals to investors seeking targeted exposure to niche market segments, combining specialized industry focus with dividend and yield strategies.

See our curated list of related YouTube videos on HLTH.

See all Tema ETFs ETFs

iShares

ETFs466

Total AUM$4551B

ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.

iShares is one of the largest ETF providers globally, known for offering a broad, diversified lineup of exchange-traded funds across multiple asset classes and investment strategies. The company operates 215 funds spanning 15 distinct families, including popular offerings in dividend income, covered call strategies, bonds, equities, ESG-focused investments, and factor-based approaches, with widely-held tickers like AGG (bond), ACWI (global equity), and AOA (allocation). iShares is characterized by its comprehensive fund ecosystem that serves both core portfolio holdings and specialized investment strategies, making it a prominent player for investors seeking both traditional and alternative income-generating ETF solutions.

See our curated list of related YouTube videos on IHI.

See all iShares ETFs

Want to go deeper?

Add these ETFs to a sample portfolio and forecast your dividend income over 5+ years — free to start, no credit card.

Compare in my portfolio Forecast income Save to watchlist

Quick verdict

HLTH (Tema Healthcare AI ETF) and IHI (iShares U.S. Medical Devices ETF) are both ETFs, but they take different approaches.

IHI currently shows a 0.63% distribution yield. HLTH has not yet established a full distribution history, so a comparable yield figure is not available.

IHI is cheaper with an expense ratio of 0.37% compared to 0.75%.

IHI has $3.56B in assets vs $8.67M for HLTH, but HLTH only launched July 2026 — AUM comparisons will become more meaningful as it builds a track record.

Still deciding? Track HLTH & IHI for free

Create a free Dividend Vision account to keep them on a watchlist, get notified when they declare dividends, and see how much income they would add to your portfolio.

Add to my watchlist See what a free account includes

Deep dive

Yield & income

On a $10,000 investment, HLTH has no reported distribution yield yet, so a monthly income estimate is not available, while IHI would produce $5.25/month, at current distribution rates.

HLTH yield—

IHI yield0.63%

Cost & efficiency

Over 10 years on $10,000, HLTH would cost approximately $750 in fees vs $370 for IHI (simplified, not compounded). The $380.00 difference may be offset by yield or performance.

HLTH ER0.75%

IHI ER0.37%

Strategy & risk

HLTH is an actively managed ETF built around healthcare exposure, while IHI is an ETF built around healthcare exposure.

HLTH beta—

IHI beta0.79

Fund details

HLTH is managed by Tema ETFs (launched 07/21/2026) with $8.67M in assets. IHI is managed by iShares (launched 05/01/2006) with $3.56B in assets.

HLTH AUM$8.67M

IHI AUM$3.56B

Ready to act?

Open in Comparator Model in portfolio See pricing

Frequently asked questions

Which of HLTH or IHI pays more dividend income?

IHI currently reports a distribution yield, while HLTH has not yet established a full distribution history. A direct income comparison is not yet meaningful — check back once both funds have published several consecutive distributions.

What is the difference between HLTH and IHI?

HLTH (Tema Healthcare AI ETF) is an actively managed ETF built around healthcare exposure, while IHI (iShares U.S. Medical Devices ETF) is an ETF built around healthcare exposure. They are issued by Tema ETFs and iShares respectively.

Can I hold both HLTH and IHI?

Yes — nothing prevents holding both. Whether the combination actually diversifies depends on how much the underlying exposures overlap, which isn't fully measurable from the data on this page; review each security's holdings, sector, and strategy before treating them as complementary.

Which has lower fees, HLTH or IHI?

HLTH has an expense ratio of 0.75% while IHI charges 0.37%. Lower fees mean more of your investment returns stay in your pocket over time.

How much income does $10,000 in HLTH vs IHI generate?

At current rates, HLTH has not established a distribution history yet, so a monthly income estimate is not available. The same in IHI would produce about $5.25 per month ($63.00 annually).

Which has performed better historically, HLTH or IHI?

HLTH has outpaced IHI over the shared window since Jul 2026, posting a 15.77% total return against 3.81%. Figures are total returns: price change plus every distribution reinvested. Past performance does not guarantee future results.

More comparisons to explore

People also compare HLTH with

People also compare IHI with

Popular comparisons

HLTH vs IHI — at a glance

Generated September 19, 2026.

Overview

HLTH and IHI both track healthcare equities, but their strategies and investment horizons diverge sharply. HLTH is a newly launched actively managed fund focusing on companies deploying artificial intelligence across drug discovery, diagnostics, and healthcare IT. IHI is a long-established passive index fund concentrating on U.S. medical device manufacturers. HLTH bets on AI-driven innovation; IHI bets on the proven, slower-moving medical device sector.

How they differ

The biggest difference is strategy: HLTH is actively managed and sector-agnostic within healthcare AI, while IHI passively tracks a fixed medical device index. HLTH launched in July 2026 with $8.67M, versus IHI's $3.56B and inception in May 2006—a 20-year gap in track record and maturity. IHI has a 0.79 beta, reflecting lower volatility relative to the broader market.

Who each is best for

HLTH: Fits investors with a multi-year horizon and conviction that AI will drive material healthcare innovation, and who are comfortable with an actively managed fund holding concentrated positions in early-stage technologies.

IHI: Fits investors seeking steady exposure to a mature, profitable, and dividend-paying subsector of healthcare with lower fees and a long operating history, and who prefer passive index-based construction.

Key risks to know

Concentration in emerging AI technologies: HLTH's focus on AI-driven healthcare is narrow and unproven at scale. The companies in the portfolio may face long development cycles, regulatory delays, or competitive disruption.

Manager skill and track record: HLTH is brand new, so there is no historical performance or evidence that its active strategy will outperform. Tema's ability to identify winning AI healthcare companies remains untested.

Medical device sector maturity and cyclicality: IHI is concentrated in an industry with slow innovation cycles and dependence on hospital capital spending and reimbursement policy. The sector is also sensitive to healthcare reform and insurance coverage decisions.

Valuation risk in AI healthcare: If the market's enthusiasm for AI healthcare moderates, or if adoption timelines slip, HLTH's valuation multiples could compress sharply, especially given its small asset base and lack of diversification. If you prefer a proven, lower-cost, income-paying path to healthcare exposure through established device makers, IHI's passive approach and $3.56B in assets offer stability and a long operating record. Past performance does not predict future results, and HLTH's short history means there is no performance history to evaluate.

AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.

Learn the method

The metrics behind this comparison, explained in the Academy.

Still deciding? Compare them against your own portfolio

See how each ETF fits alongside your real holdings — forecast future income, analyze overlap, and gauge risk. Start a free 7-day Dividend Vision trial and make the call with your full portfolio in view.

Start Free Open in Comparator Browse Screener